NAMSA and the Regulatory Affairs Professional Society (RAPS) will hold this webinar to bring awareness to the U.S. Food and Drug Administration’s (FDA) Quality System Regulation (QSR) proposed changes and what these may mean for the medical device industry and MedTech manufacturers as a whole.
BioOhio proudly supports diversity and inclusion within the bioscience and healthcare industries. Join BioOhio, Cardinal Health, and Forge Biologics to learn what makes an Employee Resource Group successful, and connect with the community to build a vision for the future of biotech and healthcare. We invite you to join us for this opportunity to convene with people and companies who have created ERGs, and those thinking of starting them. Diversity, Equity & Inclusion teams at leading bioscience companies will help guide this important discussion. This event will conclude with a networking reception.
In healthcare, we often hear the phrase “patient focus” which is designed to make decisions with the patient’s safety in mind. But all too often we forget that within the workplace, we also need to consider the safety and well-being of our sterile processing professionals who are facing the risks and doing the real work. This presentation will focus on the dangers and risks we face on a daily basis in our departments as well as provide solutions for those dangers and risks.
Join the Ian Burkhart Foundation for a night of Topgolf on Thursday, August 18, 2022, from 6 to 9 PM at Topgolf Columbus (Polaris). Funds raised at this event will support our equipment grants to provide tools for the independence of individuals with spinal cord injuries.
The U.S. healthcare market is in a continuous state of flux and uncertainty. Now more than ever, it’s imperative that pharmaceutical manufacturers partner with emerging vendors to overcome the unique market access challenges of rare disease and gene/cell therapies to avoid pitfalls and to drive a successful product launch. During this webinar, our experts will provide in-depth insights on commercialization strategy, distribution models and demonstrating therapeutic value of Rare Disease & Gene/Cell therapies for patients, payers, and providers. This event features member Michael Baldzicki, Chief Brand Officer, AscellaHealth.
On this edition of Founder's Story, Rev 1 Ventures will host a breakfast with DASI Simulations's team who performs advanced individualized computational predictive modeling powered by artificial intelligence and computer vision to better plan for improved patient outcomes and reduced costs associated with Structural Heart Disease.
A dramatic shift in regulatory opinions has occurred within the last several years regarding the concepts of Extractables and Leachables (E&L) testing of medical devices, commonly known as Chemical Characterization. Much of that change was driven by the 2020 revision to ISO 10993-18. Join NAMSA for this webinar to learn more about the foundations behind Chemical Characterization and to examine best practices deriving from it.
Grab your favorite drink (or just a drink), come learn and interact with industry experts while they discuss hot topics in Medtech. This session: Navigating the Complexities of the US Healthcare Reimbursement System
Once a year, the British-American Business Network brings together members of all 22 chapters throughout the US and UK at its Annual Transatlantic Business Conferences, for a 3-day program of high-level business discussions and networking with business executives actively involved in transatlantic business. Healthcare sessions on September 8th will features insightful speakers from OSU Wexner Medical Center, University Hospitals, Cleveland Clinic (USA/London, Eaton Corporation, BioOhio, and more.
Dayton’s biggest annual event for entrepreneurs and startup founders is fully back in person Sept. 13-15 at the Dayton Arcade and The Hub Powered by PNC.
